Septerna (SEPN) Income from Non-Controlling Interests (2024 - 2026)
Septerna's (SEPN) quarterly Income from Non-Controlling Interests came in at -$1.2 million in Q1 2026, down 935.21% year-on-year from $142000.0 in Q1 2025, and down 695.98% quarter-over-quarter from $199000.0 in Q3 2025.
Septerna (SEPN) Income from Non-Controlling Interests (2024 - 2026) Analysis & Trends
Septerna's Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at -$1.2 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,290.43 Bn | 66,290.15 Bn | - | - |
| 2 | Nanobiotix | 1,914.07 Bn | 1,914.01 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 467.97 Bn | 463.18 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.73 Bn | 115.48 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.82 Bn | 62.82 Bn | - | - |
| 8 | Argenx Se | 56.00 Bn | 50.82 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.51 Bn | 34.50 Bn | 959.66 Mn | - |
| 10 | Septerna | 1.48 Bn | 1.48 Bn | - | -1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.19 Mn |
| Sep 30, 2025 | 199,000.00 |
| Jun 30, 2025 | -22,000.00 |
| Mar 31, 2025 | 142,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | -7,000.00 |